Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Barry A Schechter"'
Autor:
Barry A. Schechter, John D. Sheppard, Christine M. Sanfilippo, Heleen H. DeCory, Penny A. Asbell
Publikováno v:
Ophthalmology and Therapy, Vol 9, Iss 1, Pp 159-173 (2019)
Abstract Introduction Understanding antibiotic resistance and toxin profiles among staphylococcal isolates in ocular infections can aid in therapeutic management and infection prevention strategies. We evaluated in vitro antibiotic resistance pattern
Externí odkaz:
https://doaj.org/article/35f34f972f534a8089eb351ce073e6cf
Autor:
Barry A Schechter, Maitee Urbieta, Jason Bacharach, Melissa Toyos, Robert Smyth-Medina, Brittany Mitchell, Jodi I Luchs
Publikováno v:
Clinical Ophthalmology.
Barry A Schechter,1 Maitee Urbieta,2 Jason Bacharach,3 Melissa Toyos,4 Robert Smyth-Medina,5 Brittany Mitchell,2 Jodi I Luchs6 1Florida Eye Microsurgical Institute, Boynton Beach, FL, USA; 2Medical Affairs North America, Sun Pharmaceutical Industries
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1fcd58a732498b1c64142974be72c43
https://www.dovepress.com/effect-of-otx-101-in-patients-with-dry-eye-disease-at-day-14-of-treatm-peer-reviewed-fulltext-article-OPTH
https://www.dovepress.com/effect-of-otx-101-in-patients-with-dry-eye-disease-at-day-14-of-treatm-peer-reviewed-fulltext-article-OPTH
Autor:
Abayomi Ogundele, M.T. Bergmann, Barry A. Schechter, Jodi Luchs, John D. Sheppard, Paul M. Karpecki
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
John Sheppard,1 Mark Bergmann,2 Barry A Schechter,3 Jodi Luchs,4 Abayomi Ogundele,5 Paul Karpecki6 1Virginia Eye Consultants, Norfolk, VA, USA; 2Apex Eye, Cincinnati, OH, USA; 3Florida Eye Microsurgical Institute, Boynton Beach, FL, USA; 4Florida Vis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9e179593084e616d459551623a2a842
http://europepmc.org/articles/PMC7811471
http://europepmc.org/articles/PMC7811471
Publikováno v:
Ophthalmology and Therapy
Ophthalmology and Therapy, Vol 9, Iss 1, Pp 159-173 (2019)
Ophthalmology and Therapy, Vol 9, Iss 1, Pp 159-173 (2019)
Understanding antibiotic resistance and toxin profiles among staphylococcal isolates in ocular infections can aid in therapeutic management and infection prevention strategies. We evaluated in vitro antibiotic resistance patterns and molecular traits
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f0899b55d07fd7e171d4ebd2105e3a
https://doi.org/10.1007/s40123-019-00223-y
https://doi.org/10.1007/s40123-019-00223-y
Autor:
Angela Justice, Ranjan Malhotra, Sidney L Weiss, John D. Sheppard, Barry A Schechter, Damien F Goldberg
Publikováno v:
Ophthalmology. 126:1230-1237
Purpose To evaluate the safety and efficacy of OTX-101, a novel aqueous nanomicellar formulation of cyclosporine (0.09%), in the treatment of patients with dry eye disease (DED). Design A randomized, multicenter, vehicle-controlled, double-masked, ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c53ca00d4af89c9678274e86262b0bca
https://doi.org/10.1016/j.ophtha.2019.03.050
https://doi.org/10.1016/j.ophtha.2019.03.050
Autor:
Paul M. Karpecki, Josh Johnston, Douglas K Devries, Jodi Luchs, George Varghese, Abayomi Ogundele, Shane R Kannarr, Robert Smyth-Medina, April L Jasper, Barry A Schechter, Charles Darby, Bridgitte Shen Lee
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 35:388-394
Purpose: Keratoconjunctivitis sicca (KCS), a multifactorial disease, is the most common ocular condition for patients seeking medical treatment and is characterized by ocular burning, stin...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e78057567c257b66b7a8a1b9e5e0eda
https://doi.org/10.1089/jop.2018.0154
https://doi.org/10.1089/jop.2018.0154
Autor:
Barry A Schechter
Publikováno v:
Clinical Ophthalmology. 13:1439-1460
Topical ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat postoperative inflammation and pain following cataract surgery and for treatment and prophylaxis of pseudophakic cystoid macular edema (CME). Bromfenac is a b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c1ec98677ebadc40bf7e73cc4b20481
https://doi.org/10.2147/opth.s208700
https://doi.org/10.2147/opth.s208700
Autor:
Albert S. Khouri, Janet B. Serle, Jason Bacharach, Dale W. Usner, Richard A. Lewis, Puiwah Braswell, Casey C. Kopczynski, Theresa Heah, Robert Benza, John W. Boyle, Michelle Butler, Leonard Robert Cacioppo, Jose F. Cardona, Valerie A. Colborn, Douglas G. Day, David T. Douglass, Sherif M. El-Harazi, Deepta Ghate, Carl Hartman, Robert F. Haverly, Barry Katzman, Max Kim, Edward Y. Koo, Michael S. Korenfeld, Bradley Kwapiszeski, Lydia Lane, Christopher Lin, Andrew Gardner Logan, Jeffrey Raymond Lozier, Henry McQuirter, Thomas K. Mundorf, Kenneth Olander, Richard J. Ou, Gregory J. Panzo, James H. Peace, Eugene E. Protzko, Robert Ritch, Kenneth Sall, Barry A. Schechter, Samuel Eric Seltzer, Pankajkumar G. Shah, Elizabeth Sharpe, Philip Lee Shettle, David G. Shulman, Inder Paul Singh, Stacy R. Smith, Stephen E. Smith, Robert John Smyth-Medina, Robert C. Sorenson, Richard Sturm, Gregory M. Sulkowski, James D. Sutton, Michael Tepedino, Julie Tsai, Carl B. Tubbs, David B. Tukel, Thomas Richard Walters, David L. Wirta
Publikováno v:
American Journal of Ophthalmology. 204:97-104
To compare the intraocular pressure (IOP)-lowering efficacy and safety of netarsudil once daily (QD) and timolol twice daily (BID).Double-masked, randomized, phase 3, noninferiority study.Patients with open-angle glaucoma or ocular hypertension (unme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::432a3f4da9a8f60609010d2756b0ba10
https://doi.org/10.1016/j.ajo.2019.03.002
https://doi.org/10.1016/j.ajo.2019.03.002
Autor:
Robert Smyth-Medina, Paul M. Karpecki, Bridgitte Shen Lee, Lee Shettle, Ranjan Malhotra, Abayomi Ogundele, Jodi Luchs, Charles Darby, Jason Bacharach, Alan G Kabat, Barry A. Schechter, Douglas K Devries
Publikováno v:
Cornea
Supplemental digital content is available in the text.
Background: Keratoconjunctivitis sicca affects 5% to 33% of the population and is often accompanied by symptoms such as burning and dryness. This pooled analysis evaluated total and central
Background: Keratoconjunctivitis sicca affects 5% to 33% of the population and is often accompanied by symptoms such as burning and dryness. This pooled analysis evaluated total and central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b7d873e636e5ed4b459647f7fb5bd03
http://europepmc.org/articles/PMC6749965
http://europepmc.org/articles/PMC6749965
Autor:
Joseph Tauber, Barry A Schechter, Jason Bacharach, Melissa M Toyos, Robert Smyth-Medina, Sidney L Weiss, Jodi I Luchs
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Tauber J, Schechter BA, Bacharach J, et al. Clin Ophthalmol.2018;12:1921–1929.On page 1927, “Safety and tolerability assessments” section,third paragraph, first sentence should read from “Fifteensubjects exited the study due to AEs: 5 subject
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8710d4a73b85540407c4ce25d841168e
https://www.dovepress.com/corrigendum2-a-phase-iiiii-randomized-double-masked-vehicle-contr-peer-reviewed-article-OPTH
https://www.dovepress.com/corrigendum2-a-phase-iiiii-randomized-double-masked-vehicle-contr-peer-reviewed-article-OPTH